Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$16.0 - $45.99 $87,536 - $251,611
-5,471 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$33.17 - $46.98 $1,724 - $2,442
52 Added 0.96%
5,471 $245,000
Q4 2021

Feb 04, 2022

SELL
$39.06 - $67.58 $1,601 - $2,770
-41 Reduced 0.75%
5,419 $232,000
Q3 2021

Nov 12, 2021

BUY
$60.13 - $77.6 $4,630 - $5,975
77 Added 1.43%
5,460 $363,000
Q2 2021

Aug 02, 2021

BUY
$50.07 - $76.78 $5,457 - $8,369
109 Added 2.07%
5,383 $395,000
Q1 2021

May 06, 2021

BUY
$58.92 - $97.33 $108,943 - $179,963
1,849 Added 53.99%
5,274 $361,000
Q4 2020

Jan 28, 2021

BUY
$43.6 - $73.05 $149,330 - $250,196
3,425 New
3,425 $230,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $733M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.